Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4474371
Max Phase: Preclinical
Molecular Formula: C180H301N53O54
Molecular Weight: 4071.70
Molecule Type: Unknown
Associated Items:
ID: ALA4474371
Max Phase: Preclinical
Molecular Formula: C180H301N53O54
Molecular Weight: 4071.70
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O
Standard InChI: InChI=1S/C180H301N53O54/c1-89(2)73-118(222-170(280)140(94(11)12)227-148(258)96(14)204-171(281)142(98(16)239)232-167(277)128(87-237)226-162(272)122(77-93(9)10)220-154(264)112(57-63-131(182)246)212-165(275)126(85-235)224-147(257)95(13)203-136(251)67-61-116(176(286)287)206-135(250)46-34-32-30-28-26-24-22-20-21-23-25-27-29-31-33-35-47-139(254)255)149(259)200-82-137(252)205-107(41-36-68-196-177(187)188)150(260)217-121(76-92(7)8)161(271)225-127(86-236)166(276)211-111(56-62-130(181)245)153(263)208-108(42-37-69-197-178(189)190)151(261)219-120(75-91(5)6)160(270)221-123(80-104-81-195-88-202-104)163(273)209-109(43-38-70-198-179(191)192)152(262)218-119(74-90(3)4)159(269)210-113(58-64-132(183)247)156(266)231-145(101(19)242)174(284)223-124(79-103-50-54-106(244)55-51-103)175(285)233-72-40-45-129(233)168(278)214-110(44-39-71-199-180(193)194)155(265)229-143(99(17)240)172(282)215-115(60-66-134(185)249)158(268)228-141(97(15)238)169(279)201-83-138(253)207-125(84-234)164(274)213-114(59-65-133(184)248)157(267)230-144(100(18)241)173(283)216-117(146(186)256)78-102-48-52-105(243)53-49-102/h48-55,81,88-101,107-129,140-145,234-244H,20-47,56-80,82-87H2,1-19H3,(H2,181,245)(H2,182,246)(H2,183,247)(H2,184,248)(H2,185,249)(H2,186,256)(H,195,202)(H,200,259)(H,201,279)(H,203,251)(H,204,281)(H,205,252)(H,206,250)(H,207,253)(H,208,263)(H,209,273)(H,210,269)(H,211,276)(H,212,275)(H,213,274)(H,214,278)(H,215,282)(H,216,283)(H,217,260)(H,218,262)(H,219,261)(H,220,264)(H,221,270)(H,222,280)(H,223,284)(H,224,257)(H,225,271)(H,226,272)(H,227,258)(H,228,268)(H,229,265)(H,230,267)(H,231,266)(H,232,277)(H,254,255)(H,286,287)(H4,187,188,196)(H4,189,190,197)(H4,191,192,198)(H4,193,194,199)/t95-,96-,97+,98+,99+,100+,101+,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,140-,141-,142-,143-,144-,145-/m0/s1
Standard InChI Key: SGIDMYDYTBFBSN-TYRZRTKUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 4071.70 | Molecular Weight (Monoisotopic): 4069.2436 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2017) Amylin and calcitonin receptor agonist, |
Source(1):